Embryonal carcinoma with falsely positive elevation of serum alpha-fetoprotein after curative therapy: a case report.
An elevated serum alpha-fetoprotein is an important serum and cell marker in nonseminomatous testicular cancer. While the sensitivity of an elevated alpha-fetoprotein is 20 to 70 per cent, depending upon clinical stage subgrouping, the specificity is 100 per cent, since no falsely positive elevation of alpha-fetoprotein has been reported. We report a case of persistent falsely positive elevation of alpha-fetoprotein after curative therapy of embryonal carcinoma.
D000328:Adult; D003131:Combined Modality Therapy; D005189:False Positive Reactions; D006801:Humans; D008297:Male; D013724:Teratoma / Q000175:diagnosis / Q000628:therapy*; D013736:Testicular Neoplasms / Q000175:diagnosis / Q000628:therapy*; D000509:alpha-Fetoproteins / Q000032:analysis*
D000509:alpha-Fetoproteins